Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
GALT compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
GALT
Galectin Therapeutics Inc
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
GALT
Galectin Therapeutics Inc
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
GALT, solid
LLY, dashed
GALT
Galectin Therapeutics Inc
Change
2.98
▼
−14.20%
· post 2.98
Mkt cap
$301.0M
Revenue
—
Revenue
—
LLY
ELI Lilly & Co
Change
1,371.32
▼
−3.29%
· post 1,363.77
Closed
Nov 5 '26
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Closed
Nov 5 '26
GALT
Galectin Therapeutics Inc
vs
LLY
ELI Lilly & Co
2.98
▼
−14.20%
post 2.98
Price
1,371.32
▼
−3.29%
post 1,363.77
$301.0M
Mkt cap
$1.2T
—
Revenue
$24.4B
Q3 FY26
—
Revenue
$65.2B
FY25
Change
Change
GALT
2.98
▼
−14.20%
vs
LLY
1,371.32
▼
−3.29%
Closed
Nov 5 '26